Abo Bibliothek: Guest
Critical Reviews™ in Immunology

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 1040-8401

ISSN Online: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Overexpressed Cell Surface Interleukin-4 Receptor Molecules Can Be Successfully Targeted for Antitumor Cytotoxin Therapy

Volumen 21, Ausgabe 1-3, 2001, 12 pages
DOI: 10.1615/CritRevImmunol.v21.i1-3.200
Get accessGet access

ABSTRAKT

A variety of human solid cancer cell lines and primary cell cultures has been reported to overexpress high-affinity receptors (R) for interleukin-4 (IL-4), a pleiotropic immunoregulatory cytokine. The significance of IL-4R expression is not known; however, IL-4 is able to upregulate adhesion molecules, inhibit cell proliferation, and mediate signal transduction in tumor cell lines. To target IL-4R, we produced a chimeric protein composed of a circular permuted IL-4 and a mutated form of Pseudomonas exotoxin [termed IL4(38-37)-PE38KDEL or cpIL4-PE]. The recombinant cpIL4-PE was highly cytotoxic to cancer cells, but not toxic to normal B cells, T cells, monocytes, and CD34+, even though these cells express detectable numbers of IL-4R. The cytotoxicity was specific because excess of recombinant IL-4 neutralized the cpIL4-PE effect. To further develop this molecule, in vivo antitumor activity was tested in animal models of human cancer. This agent showed remarkable antitumor activity in AIDS-Kaposi’s sarcoma, glioblastoma multiforme, and breast cancer models in immunodeficient animals. cpIL4-PE caused partial or complete regression of established human tumors. Preclinical efficacy and toxicity studies provided a therapeutic window in which this cancer-targeted agent could be used. On the basis of these studies, we initiated a Phase I clinical trial for the treatment of recurrent glioblastoma multiforme. Our preliminary clinical results suggest that cpIL4-PE has antitumor activity against the deadliest form of brain tumors, without detectable toxicity to normal brain tissues. Thus, IL-4 receptors represent novel targets for cancer cytotoxin therapy.

REFERENZIERT VON
  1. Lima Flavia R.S., Kahn Suzana Assad, Soletti Rossana C., Biasoli Deborah, Alves Tercia, da Fonseca Anna Carolina C., Garcia Celina, Romão Luciana, Brito José, Holanda-Afonso Rosenilde, Faria Jane, Borges Helena, Moura-Neto Vivaldo, Glioblastoma: Therapeutic challenges, what lies ahead, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1826, 2, 2012. Crossref

  2. Garland Linda, Gitlitz Barbara, Ebbinghaus Scot, Pan Henry, de Haan Hans, Puri Raj K, Von Hoff Daniel, Figlin Robert, Phase I Trial of Intravenous IL-4 Pseudomonas Exotoxin Protein (NBI-3001) in Patients with Advanced Solid Tumors That Express the IL-4 Receptor, Journal of Immunotherapy, 28, 4, 2005. Crossref

  3. Long Ton That Ai, Kalantarov Gavreel, Chudner Alexandra, Trakht Ilya, A Dual-Chamber System for Screening Cytotoxic Effects of Hybridoma-Produced Antibodies, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 32, 4, 2013. Crossref

  4. Zhu Xiaoying, Tao Kun, Li Yajuan, Li Shenfeng, Zhang Lijun, Wang Dong, Zhong Liang, Feng Wenli, A new recombinant immunotoxin hscFv-ETA’ demonstrates specific cytotoxicity against chronic myeloid leukemia cells in vitro, Immunology Letters, 154, 1-2, 2013. Crossref

  5. Klementiev Boris, Enevoldsen Maj N., Li Shizhong, Carlsson Robert, Liu Yawei, Issazadeh-Navikas Shohreh, Bock Elisabeth, Berezin Vladimir, Antiinflammatory properties of a peptide derived from interleukin-4, Cytokine, 64, 1, 2013. Crossref

  6. Prokopchuk O, Liu Y, Henne-Bruns D, Kornmann M, Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions, British Journal of Cancer, 92, 5, 2005. Crossref

  7. Newman Gale, Gonzalez-Perez Ruben Rene, Leptin–cytokine crosstalk in breast cancer, Molecular and Cellular Endocrinology, 382, 1, 2014. Crossref

  8. Li Yan Michael, Hall Walter A., Targeted Toxins in Brain Tumor Therapy, Toxins, 2, 11, 2010. Crossref

  9. Ishige Kazunori, Shoda Junichi, Kawamoto Toru, Matsuda Sachiko, Ueda Tetsuya, Hyodo Ichinosuke, Ohkohchi Nobuhiro, Puri Raj K., Kawakami Koji, Potentin vitroandin vivoantitumor activity of interleukin-4-conjugatedPseudomonasexotoxin against human biliary tract carcinoma, International Journal of Cancer, 123, 12, 2008. Crossref

  10. Hansen Morten, Hjortø Gertrud M., Met Özcan, Jakobsen Mogens H., Svane Inge M., Larsen Niels B., Cell culture plastics with immobilized interleukin-4 for monocyte differentiation, Journal of Biomedical Materials Research Part A, 96A, 2, 2011. Crossref

  11. Carlson Linda E., Speca Michael, Patel Kamala D., Goodey Eileen, Mindfulness-Based Stress Reduction in Relation to Quality of Life, Mood, Symptoms of Stress, and Immune Parameters in Breast and Prostate Cancer Outpatients, Psychosomatic Medicine, 65, 4, 2003. Crossref

  12. Rustamzadeh Edward, Low Walter C., Vallera Daniel A., Hall Walter A., Immunotoxin therapy for CNS tumor, Journal of Neuro-oncology, 64, 1-2, 2003. Crossref

  13. Kurtz David M., Tschetter Loren K., Allred Jacob B., Geyer Susan M., Kurtin Paul J., Putnam Wesley D., Rowland Kendrith M., Wiesenfeld Martin, Soori Gamini S., Tenglin Richard C., Bernath Albert M., Witzig Thomas E., Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51, Leukemia & Lymphoma, 48, 7, 2007. Crossref

  14. Chi Lianhua, Na Moon-Hee, Jung Hyun-Kyung, Vadevoo Sri Murugan Poongkavithai, Kim Cheong-Wun, Padmanaban Guruprasath, Park Tae-In, Park Jae-Yong, Hwang Ilseon, Park Keon Uk, Liang Frank, Lu Maggie, Park Jiho, Kim In-San, Lee Byung-Heon, Enhanced delivery of liposomes to lung tumor through targeting interleukin-4 receptor on both tumor cells and tumor endothelial cells, Journal of Controlled Release, 209, 2015. Crossref

  15. Landi Stefano, Bottari Fabio, Gemignani Federica, Gioia-Patricola Lydie, Guino Elisabeth, Osorio Alfonso, Oca Javier de, Capella Gabriel, Canzian Federico, Moreno Victor, Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk, European Journal of Cancer, 43, 4, 2007. Crossref

  16. Beseth Bryce D, Cameron Robert B, Leland Pamela, You Liang, Varricchio Frederick, Kreitman Robert J, Maki Richard A, Jablons David M, Husain Syed R, Puri Raj K, Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts, The Annals of Thoracic Surgery, 78, 2, 2004. Crossref

  17. Kay Neil E., Pittner Brian T., IL-4 Biology: Impact on Normal and Leukemic CLL B Cells, Leukemia & Lymphoma, 44, 6, 2003. Crossref

  18. Yang Chih-Yung, Liu Hong-Wen, Tsai Ya-Ching, Tseng Ju-Yu, Liang Shu-Ching, Chen Chin-Yau, Lian Wei-Nan, Wei Ming-Cheng, Lu Maggie, Lu Ruey-Hwa, Lin Chi-Hung, Jiang Jeng-Kai, Interleukin-4 receptor-targeted liposomal doxorubicin as a model for enhancing cellular uptake and antitumor efficacy in murine colorectal cancer, Cancer Biology & Therapy, 16, 11, 2015. Crossref

  19. Frankel Arthur E., Kreitman Robert J., CLL immunotoxins, Leukemia Research, 29, 9, 2005. Crossref

  20. Kawakami Koji, Kawakami Mariko, Puri Raj K, Cytokine receptor as a sensitizer for targeted cancer therapy, Anti-Cancer Drugs, 13, 7, 2002. Crossref

  21. Kay Neil E., Bone Nancy D., Lee Yean K., Jelinek Diane F., Leland Pamela, Battle Traci E., Frank David A., Puri Raj K., A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells, Leukemia Research, 29, 9, 2005. Crossref

  22. Yoon Dennis J., Liu Christina T., Quinlan Devin S., Nafisi Parsa M., Kamei Daniel T., Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for Cancer, Annals of Biomedical Engineering, 39, 4, 2011. Crossref

  23. Kawakami Koji, Kawakami Mariko, Kioi Mitomu, Husain Syed R., Puri Raj K., Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model, Journal of Neurosurgery, 101, 6, 2004. Crossref

  24. Ul-Haq Zaheer, Naz Sehrish, Mesaik M. Ahmed, Interleukin-4 receptor signaling and its binding mechanism: A therapeutic insight from inhibitors tool box, Cytokine & Growth Factor Reviews, 32, 2016. Crossref

  25. Ingram Nicola, Northwood Emma L., Perry Sarah L., Marston Gemma, Snowden Helen, Taylor John C., Scott Nigel, Bishop D. Timothy, Coletta P. Louise, Hull Mark A., Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case–control epidemiological observations, Carcinogenesis, 34, 10, 2013. Crossref

  26. Krajewska Julia B., Bartoszek Adrian, Fichna Jakub, New Trends in Liposome-based Drug Delivery in Colorectal Cancer, Mini-Reviews in Medicinal Chemistry, 19, 1, 2018. Crossref

  27. Kay Neil E., Hamblin Terry J., Jelinek Diane F., Dewald Gordon W., Byrd John C., Farag Sherif, Lucas Margaret, Lin Thomas, Chronic Lymphocytic Leukemia, Hematology, 2002, 1, 2002. Crossref

  28. Kawakami Koji, Puri Raj K., Interleukin-4/13 and Cancer, in Cytokines in the Genesis and Treatment of Cancer, 2007. Crossref

  29. Kawakami Mariko, Kawakami Koji, Kioi Mitomu, Leland Pamela, Puri Raj K., Hodgkin lymphoma therapy with interleukin-4 receptor–directed cytotoxin in an infiltrating animal model, Blood, 105, 9, 2005. Crossref

  30. Bai Xue-Di, Cao Xue-Wei, Chen Yi-Hui, Fu Long-Yun, Zhao Jian, Wang Fu-Jun, Constructing a better binding peptide for drug delivery targeting the interleukin-4 receptor, Journal of Drug Targeting, 28, 9, 2020. Crossref

  31. Green Daniel S, Husain Syed R, Johnson Chase L, Sato Yuki, Han Jing, Joshi Bharat, Hewitt Stephen M, Puri Raj K, Zoon Kathryn C, Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer, Immunotherapy, 11, 6, 2019. Crossref

  32. Shi Jingwei, Song Xujun, Traub Benno, Luxenhofer Michael, Kornmann Marko, Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer, International Journal of Molecular Sciences, 22, 6, 2021. Crossref

  33. Eguchi J, Hiroishi K, Ishii S, Baba T, Matsumura T, Hiraide A, Okada H, Imawari M, Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-α transduction, Gene Therapy, 12, 9, 2005. Crossref

  34. Burt Bryan M., Bader Andrew, Winter Daniel, Rodig Scott J., Bueno Raphael, Sugarbaker David J., Expression of Interleukin-4 Receptor Alpha in Human Pleural Mesothelioma Is Associated with Poor Survival and Promotion of Tumor Inflammation, Clinical Cancer Research, 18, 6, 2012. Crossref

  35. Shimamura Takeshi, Royal Richard E., Kioi Mitomu, Nakajima Atsushi, Husain Syed R., Puri Raj K., Interleukin-4 Cytotoxin Therapy Synergizes with Gemcitabine in a Mouse Model of Pancreatic Ductal Adenocarcinoma, Cancer Research, 67, 20, 2007. Crossref

  36. Kim Hag Dong, Yu Su-Jin, Kim Hee Suk, Kim Yong-Jin, Choe Jeong Min, Park Yun Gyu, Kim Joon, Sohn Jeongwon, Interleukin-4 Induces Senescence in Human Renal Carcinoma Cell Lines through STAT6 and p38 MAPK, Journal of Biological Chemistry, 288, 40, 2013. Crossref

  37. Li Zhiguang, Jiang Jing, Wang Zibing, Zhang Jinhua, Xiao Mingjie, Wang Chunhui, Lu Yu, Qin Zhihai, Endogenous Interleukin-4 Promotes Tumor Development by Increasing Tumor Cell Resistance to Apoptosis, Cancer Research, 68, 21, 2008. Crossref

  38. Li Yan Michael, Hall Walter A, Cell Surface Receptors in Malignant Glioma, Neurosurgery, 69, 4, 2011. Crossref

  39. Kioi Mitomu, Takahashi Satoru, Kawakami Mariko, Kawakami Koji, Kreitman Robert J., Puri Raj K., Expression and Targeting of Interleukin-4 Receptor for Primary and Advanced Ovarian Cancer Therapy, Cancer Research, 65, 18, 2005. Crossref

  40. Kawakami Koji, Kawakami Mariko, Puri Raj K., IL-13 Receptor-Targeted Cytotoxin Cancer Therapy Leads to Complete Eradication of Tumors with the Aid of Phagocytic Cells in Nude Mice Model of Human Cancer, The Journal of Immunology, 169, 12, 2002. Crossref

Zukünftige Artikel

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain